Tested's Adam Savage paired up with Medtronic to offer his commentary on what can contribute to a longer lifespan, including possible differences between men's and women's health. Former "MythBusters" star Adam Savage is exploring the science of longevity, asking how lifestyle choices, stress and even sleep affect how long we live. Savage, now a YouTube creator and head of the channel Tested, has partnered with health technology company Medtronic to engage in discussions about longevity. While not a researcher himself, he has taken a deep dive into scientific insights from experts and reflected on his own experiences. "Longevity has always been a fascination for me," Savage told Fox News Digital in an exclusive interview.

NVIDIA is deepening its efforts to fight cancer using AI. The GPU maker is teaming with Medtronic to build AI into the GI Genius endoscopy tool (shown below). The two will use NVIDIA's IGX hardware and Holoscan medical platform to help detect the polyps that can lead to colorectal cancer. Doctors will get "AI-enhanced" diagnostic images, the companies say. The first GI Genius systems built with NVIDIA tech are expected to arrive later this year.

The global medical industry experienced a 13% rise in new job postings related to artificial intelligence in Q3 2022 compared with the previous quarter, according to GlobalData's Jobs Analytics. This compares to a 13% increase in the previous quarter and a 39% increase versus Q3 2021. Notably, Software and Web Developers, Programmers, and Testers jobs accounted for a 16% share of the global medical industry's artificial intelligence-related total new job postings in Q3 2022, down 11% over the prior quarter. Software and Web Developers, Programmers, and Testers, with a share of 16%, emerged as the top artificial intelligence-related job roles within the medical industry in Q3 2022, with new job postings drop by 11% quarter-on-quarter. General and Operations Managers came in second with a share of 5% in Q3 2022, with new job postings rise by 4% over the previous quarter.

Michelle Wu, cofounder and CEO and KK (Qiang Kou 寇强) tech cofounder at Nyquist Data, an AI powered ... [ ] cloud-based platform providing business, clinical, and regulatory intelligence and analytics for medical devices and pharmaceuticals companies How long does it take to get FDA approval for a heart-failure drug? It sounds like a simple question, but without the help of an artificial intelligence (AI) powered MedTech cloud-based platform, it could take months and millions of dollars to find out. The market size for AI in healthcare is projected to reach $187.95 billion by 2030, according to Precedence Research. When Michelle Wu was first asked this question, global clinical and regulatory healthcare information was publicly available, but it was scattered around the world in different databases and languages. Worse yet, keywords were misspelled or there were handwritten notes included in the databases, making what should be searchable unsearchable.

For decades, heart specialists have been implanting insertable cardiac monitors (ICMs) to track sporadic heart arrhythmia. These subcutaneous devices have become the preferred diagnostic tool for prolonged heart rhythm monitoring since they were first developed in 1990. But ICM false alerts have been a problem ever since. Now, however, physicians are using artificial intelligence to reduce the incidence of ICM false positives. Last summer, Medtronic, a global leader in healthcare technology, introduced new AI algorithms to reduce false alerts from irregular or rapid heart rhythms and long pauses between heartbeats.

The Internet of Medical Things (IoMT) is rapidly gaining traction as healthcare organizations seek new methods to innovate and stay current with technology in order to help patients and clinicians better monitor and track ailments. The Internet of Things (IoT) has grown rapidly in healthcare in recent years, and the pandemic has accelerated the emergence of IoMT, which several governments have widely used as a strategy to prevent the virus's spread. The industry has one of the greatest rates of IoT investment and growth. A 2020 FICCI-BCG report states that: "Health tracking devices and electronic health records combined with AI and Machine Learning (ML) technologies will not only pave the way for efficient chronic disease management but will also lead to the emergence of efficient clinical decision support systems." The EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD) System as well as the EMPOWER Modular Pacing System (MPS), which is planned to be the first leadless pacemaker capable of providing both bradycardia pacing support and anti-tachycardia pacing, make up the mCRM System.

To read the full story, subscribe or sign in. A 2,000-patient U.K. study has been set up to generate real-world evidence of the value of using AI technology to detect bowel polyps (adenomas) during colonoscopy procedures. The aim is to show whether Medtronic plc's GI Genius system improves the detection of polyps when deployed in both expert centers and non-specialist units, in the routine diagnostic screening of patients referred from primary care or through the national fecal immunochemical testing program.

The concept of robotics is as wide as the landmass of the planet. Robotics is a combination of applied science, engineering, and computer science. Perhaps the healthcare industry, one of the most profitable industries, across the world seeks robot applications to progress. Subsequently, medical robotics companies have earned a great deal of trust across the world and are booming remarkably. Technologies used for medical robotics include mechanisms such as AI-powered machinery, software, and applications, physical as well as virtual.

Medtronic, the world's largest medical device company, is significantly increasing its investments into AI and other technologies, in what it says is an effort to help the health care industry catch up with other industries. While many other industries have embraced technology, health care has been slower. Studies reveal that only 20% of consumers would trust AI-generated health care advice. VentureBeat interviewed Torod Neptune, Medtronic's senior vice president and chief communications officer, and Gio Di Napoli, president of Medtronic's Gastrointestinal Unit, to discuss the company's vision of the future of health care technology. Neptune spoke about Medtronic's transition beyond traditional med tech to more innovative solutions using AI.

Michael Wallace has performed hundreds of colonoscopies in his 20 years as a gastroenterologist. He thinks he's pretty good at recognizing the growths, or polyps, that can spring up along the ridges of the colon and potentially turn into cancer. Sometimes the polyps are flat and hard to see. Other times, doctors just miss them. "We're all humans," says Wallace, who works at the Mayo Clinic.